Mark Melancon signs with San Diego
He's grinded out a productive career.....didn't see that coming......
This potentially looks like one of the best deals of the offseason. As long as he is healthy, he’s really good. Hard to believe he’s only 28 still. Seems like he’s been around forever.Solid signing for the Mets, high upside for a 4/5 guy in the rotation. Also gives some flexibility with Luchessi now going to the bullpen.
This potentially looks like one of the best deals of the offseason. As long as he is healthy, he’s really good. Hard to believe he’s only 28 still. Seems like he’s been around forever.
Huh. Didn’t realize that part. His career ERA of 3.84 is definitely solid, though, and he should be right in his prime. It’s not big money. It seems like a decent risk. I don’t see how he’s more of a risk than a Kluber, Garrett Richards or Paxton at similar money?? I think the Mets did well here.Peripherals tell a little bit of a different story. He had an aberrant .243 BABIP in 2020 while he pitched to that 2.70 ERA. His FIP was actually 4.56.
I'm just saying.....there's a reason he didn't get signed until camps already opened.
Huh. Didn’t realize that part. His career ERA of 3.84 is definitely solid, though, and he should be right in his prime. It’s not big money. It seems like a decent risk. I don’t see how he’s more of a risk than a Kluber, Garrett Richards or Paxton at similar money?? I think the Mets did well here.
Sounds like you are a little more skeptical than I am. I definitely get it. I just thought the comps I provided were pretty good. How would you rank Kluber, Richards, Paxton and Walker in terms of expected success in 2021?Outside of the shaky peripherals, he averaged 4 2/3 IP per start last year, only a hair over 5 IP for his career.
They can hit a little bit in the NL East.
Time will tell.
Sounds like you are a little more skeptical than I am. I definitely get it. I just thought the comps I provided were pretty good. How would you rank Kluber, Richards, Paxton and Walker in terms of expected success in 2021?
Odorizzi had the one great year in 2019, but he was just awful in 2020. I know we can dismiss some of these bad 2020 stats due to the bizarre nature of the season, but it seems like he only shows up every other year. Fortunately, this would be his “good” year, but that 2020 campaign definitely is costing him some money right now.Not sure 2 years with an option was a great deal for the Mets, but he is a solid #4/5 pitcher. The problem is that most 4/5 starters came in this year a lot cheaper than that.
They probably could have gotten Odorizzi for the same sort of deal and he's a better pitcher.
Sounds like you would rank Walker at the top for those 4 guys? I think I would, too.Re: Kluber-I have zero idea what to expect from a guy who's logged a grand total of 36 innings over the last 2 years. I know I sure as shit wouldn't have given him 11 million dollars.
Richards is a similar story-too much unknown for that kind of scratch. He hasn't made more than 16 starts in a season in 6 years.
Paxton I think was only $8M? He can be dominant if he's healthy, but he's never healthy.
Odorizzi was hit in the chest by a line drive in his 4th start and missed the rest of the season. A couple of bad outings do not make a bad season.Odorizzi had the one great year in 2019, but he was just awful in 2020. I know we can dismiss some of these bad 2020 stats due to the bizarre nature of the season, but it seems like he only shows up every other year. Fortunately, this would be his “good” year, but that 2020 campaign definitely is costing him some money right now.